PriceSensitive

Radient Technologies (TSXV:RTI) files Health Canada applications, delays annual report

Cannabis
TSXV:RTI
09 August 2021 12:30 (EDT)
Radient Technologies - CEO, Harry Kaura

Source: Radient Technologies.

Radient Technologies (RTI) has provided a pair of corporate updates covering financial statements and Health Canada sales licenses.

2020 annual financials

The company is temporarily delaying its 2020 annual financial statements. This is due to the impending completion of its acquisition of Tunaaaaroom and PBR Labs, as well as an internal review of the business.

The review is evaluating other strategic M&A opportunities to complement the aforementioned acquisitions.

Radient expects to complete the acquisitions by the end of August, at which time it will file its financial statements.

Health Canada applications

The company recently submitted two applications to Health Canada regarding its sales licenses.

The first is for an amendment to its existing sales license to include authorization for online medical cannabis sales directly to registered clients across Canada.

The second is for an additional sales license allowing for the sale of dried flower. 

 Harry Kaura, Radient’s CEO, commented,

“Customer response to our products and brands available in retail cannabis stores has been very positive, and we are very excited at the potential of adding an e-commerce based sales channel to our growing platform. I believe Canadian cannabis consumers will be very pleased with how we intend to launch our online sales channel and continue to deliver positive consumer experiences by providing quality products cannabis connoisseurs love at prices that out-compete their current suppliers.”

Radient Technologies is a commercial manufacturer of cannabis extracts and packaged products.

Radient Technologies (RTI) is up by 6.67 per cent and is currently trading at $0.08 per share as of 11:32 am ET.

Related News